For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What are the growth projections for the vitamin biomarkers market from 2024 to 2029?
The vitamin biomarkers market size has grown rapidly in recent years. It will grow from $3.59 billion in 2024 to $4.06 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growing awareness of vitamin deficiencies, increasing prevalence of chronic diseases, rising demand for personalized nutrition, increasing research on nutritional biomarkers, and growing geriatric population.
The vitamin biomarkers market size is expected to see rapid growth in the next few years. It will grow to $6.56 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing adoption of digital health solutions, increasing focus on early disease detection, rising demand for home-based testing kits, increasing healthcare expenditure, and rising consumer interest in health and wellness. Major trends in the forecast period include integration of wearable health technology, development of multi-biomarker panels, advancements in high-throughput screening methods, development of novel biomarker-based tests, and enhanced digital and remote health monitoring.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21003&type=smp
What strategic initiatives by market players are driving vitamin biomarkers industry growth?
The increasing prevalence of nutrition deficiencies is expected to propel the growth of the vitamin biomarkers market going forward. Nutrition deficiencies refer to a lack of essential nutrients in the diet, leading to adverse health effects. Poor dietary habits, inadequate access to diverse foods, and socio-economic factors drive the increasing prevalence of nutrition deficiencies. Vitamin biomarkers are used to diagnose nutrition deficiencies by measuring specific vitamins in the blood to assess nutritional status and guide interventions. For instance, in July 2023, according to a report by the Food and Agriculture Organization, an Italy-based non-profit organization, the prevalence of undernourishment (PoU) (percentage of a population whose dietary energy intake is insufficient to meet the minimum energy requirements for maintaining a healthy and active life.) impacted approximately 9.2% of the global population in 2022, up from 7.9% in 2021. Further, prevalence in Africa increased by 0.3 percentage points, from 19.4% in 2021 to 19.7% in 2022. Therefore, the increasing prevalence of nutrition deficiencies will drive the growth of the vitamin biomarkers market.
Vitamin Biomarkers Market Driver: Personalized Medicine Driving Growth In The Vitamin Biomarkers Market
The increasing focus on personalized medicine is expected to propel the growth of the vitamin biomarkers market going forward. Personalized medicine refers to a medical approach that tailors treatment and healthcare strategies to the individual characteristics, genetics, and needs of each patient. Personalized medicine is attributed to advancements in genomics, biotechnology, and data analytics, allowing treatments to be customized based on individual genetic profiles and other personal health data. Vitamin biomarkers help personalized medicine by providing insights into an individual’s nutritional status and metabolic processes, enabling tailored treatment plans to optimize health outcomes. For instance, in February 2024, according to Personlaized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing focus on personalized medicine is driving the growth of the vitamin biomarkers market.
What emerging segments are shaping the future landscape of the vitamin biomarkers industry?
The vitamin biomarkers market covered in this report is segmented –
1) By Biomarker Type: Serum Retinol (Vitamin A); Ascorbic Acid (Vitamin C); Serum 25(OH)D (Vitamin D); Serum Alpha-tocopherol (Vitamin E); Serum Prothrombin (Vitamin K); Serum Thiamine Diphosphate (Vitamin B1); Serum Glycolate (Vitamin B2); Serum Niacin (Vitamin B3); Serum Plasma PLP (Vitamin B6); Other Biomarker Types
2) By Product: Analyzers; Test Kits; Reagents And Consumables
3) By Testing Method: Enzyme Linked Immunosorbent Assay (ELISA); Liquid Chromatography With Tandem Mass Spectrometry (LC MS MS); High Performance Liquid Chromatography (HPLC); Chemiluminescent Immunoassay (CLIA)
4) By End User: Hospitals; Diagnostic Laboratories; Ambulatory Diagnostic Centers; Homecare Settings
Subsegments:
1) By Serum Retinol (Vitamin A): Retinol Measurement Kits; Retinol Assay Reagents
2) By Ascorbic Acid (Vitamin C): Vitamin C Detection Kits; Ascorbic Acid Assay Reagents
3) By Serum 25(OH)D (Vitamin D): Vitamin D Testing Kits; 25-Hydroxyvitamin D Assay Reagents
4) By Serum Alpha-tocopherol (Vitamin E): Alpha-tocopherol Measurement Kits; Vitamin E Assay Reagents
5) By Serum Prothrombin (Vitamin K): Prothrombin Time Testing Kits; Vitamin K Assay Reagents
6) By Serum Thiamine Diphosphate (Vitamin B1): Thiamine Measurement Kits; Vitamin B1 Assay Reagents
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/vitamin-biomarkers-global-market-report
How are key players in the vitamin biomarkers market strengthening their market position?
Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc
Which geographic areas are contributing significantly to the growth of the vitamin biomarkers sector?
North America was the largest region in the vitamin biomarkers market in 2024. The regions covered in the vitamin biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Vitamin Biomarkers Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21003
Need Customized Data On Vitamin Biomarkers Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=21003&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
